Checkpoint molecule PD-1-assisted CD8⁺ T lymphocyte count in tumor microenvironment predicts overall survival of patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors

Jiaxi YaoDepartment of Urology, Zhongshan Hospital, Fudan University, Shanghai, China, [email protected]; [email protected]

Wei XiDepartment of Urology, Zhongshan Hospital, Fudan University, Shanghai, China, [email protected]; [email protected]

Yanjun ZhuDepartment of Urology, Zhongshan Hospital, Fudan University, Shanghai, China, [email protected]; [email protected]

Hang WangDepartment of Urology, Zhongshan Hospital, Fudan University, Shanghai, China, [email protected]; [email protected]

Xiaoyi HuDepartment of Urology, Zhongshan Hospital, Fudan University, Shanghai, China, [email protected]; [email protected]Correspondence[email protected] [email protected]

Jianming GuoDepartment of Urology, Zhongshan Hospital, Fudan University, Shanghai, China, [email protected]; [email protected]Correspondence[email protected] [email protected]

Pages 3419-3431 | Published online: 11 Sep 2018

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

SiegelRLMillerKDJemalACancer statistics, 2018CA Cancer J Clin201868173029313949
PubMed Web of Science ®Google Scholar
JoshiSSHandorfEAZibelmanMTreatment facility volume and survival in patients with metastatic renal cell carcinoma: a registry-based analysisEur Urol Epub201864
Google Scholar
EscudierBPortaCSchmidingerMRenal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-upAnn Oncol201425Suppl 3iii49iii5625210086
PubMed Web of Science ®Google Scholar
WallisCJDKlaassenZBhindiBFirst-line systemic therapy for metastatic renal cell carcinoma: a systematic review and network meta-analysisEur Urol201813183025430259
Google Scholar
HengDYXieWReganMMPrognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter studyJ Clin Oncol200927345794579919826129
PubMed Web of Science ®Google Scholar
MatsumotoHThikeAALiHIncreased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancerBreast Cancer Res Treat2016156223724726960711
PubMed Web of Science ®Google Scholar
BhattacharyaNYuanRPrestwoodTRNormalizing microbiota-induced retinoic acid deficiency stimulates protective CD8(+) T cell-mediated immunity in colorectal cancerImmunity201645364165527590114
PubMed Web of Science ®Google Scholar
WeissJMGregory AlvordWQuiñonesOAStaufferJKWiltroutRHCD40 expression in renal cell carcinoma is associated with tumor apoptosis, CD8(+) T cell frequency and patient survivalHum Immunol201475761462024801648
PubMed Web of Science ®Google Scholar
NakanoOSatoMNaitoYProliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunityCancer Res200161135132513611431351
PubMed Web of Science ®Google Scholar
TopalianSLDrakeCGPardollDMImmune checkpoint blockade: a common denominator approach to cancer therapyCancer Cell201527445046125858804
PubMed Web of Science ®Google Scholar
PardollDMThe blockade of immune checkpoints in cancer immunotherapyNat Rev Cancer201212425226422437870
PubMed Web of Science ®Google Scholar
YaoSZhuYChenLAdvances in targeting cell surface signalling molecules for immune modulationNat Rev Drug Discov201312213014623370250
PubMed Web of Science ®Google Scholar
GiraldoNABechtEPagèsFOrchestration and prognostic significance of immune checkpoints in the microenvironment of primary and metastatic renal cell cancerClin Cancer Res201521133031304025688160
PubMed Web of Science ®Google Scholar
PanerGPStadlerWMHanselDEMontironiRLinDWAminMBUpdates in the eighth edition of the tumor-node-metastasis staging classification for urologic cancersEur Urol201873456056929325693
PubMed Web of Science ®Google Scholar
CompératEMBurgerMGonteroPGrading of urothelial carcinoma and the new “World Health Organisation classification of tumours of the urinary system and male genital organs 2016”Eur Urol Focus Epub2018120
Google Scholar
EisenhauerEATherassePBogaertsJNew response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)Eur J Cancer200945222824719097774
PubMed Web of Science ®Google Scholar
LingAEdinSWikbergMLÖbergÅPalmqvistRThe intratumoural subsite and relation of CD8(+) and FOXP3(+) T lymphocytes in colorectal cancer provide important prognostic cluesBr J Cancer2014110102551255924675384
PubMed Web of Science ®Google Scholar
GeorgeDJMartiniJFStaehlerMImmune biomarkers predictive for disease-free survival with adjuvant sunitinib in high-risk locoregional renal cell carcinoma: from randomized phase III S-TRAC studyClin Cancer Res20182471554156129374054
PubMed Web of Science ®Google Scholar
IacovelliRNolèFVerriEPrognostic role of PD-L1 expression in renal cell carcinoma. A systematic review and meta-analysisTarget Oncol201611214314826429561
PubMed Web of Science ®Google Scholar
GranierCDarianeCCombePTim-3 expression on tumor-infiltrating PD-1(+)CD8(+) T cells correlates with poor clinical outcome in renal cell carcinomaCancer Res20177751075108227872087
PubMed Web of Science ®Google Scholar
SantoniMBerardiRAmantiniCRole of natural and adaptive immunity in renal cell carcinoma response to VEGFR-TKIs and mTOR inhibitorInt J Cancer2014134122772277724114790
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Checkpoint molecule PD-1-assisted CD8⁺ T lymphocyte count in tumor microenvironment predicts overall survival of patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Checkpoint molecule PD-1-assisted CD8+ T lymphocyte count in tumor microenvironment predicts overall survival of patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Checkpoint molecule PD-1-assisted CD8⁺ T lymphocyte count in tumor microenvironment predicts overall survival of patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors